A look at brain tumor patients by age at one hospital in Romania
Original title: Integrated clinico-radio-molecular profiling of diffuse gliomas across age groups: a Romanian single-center cohort study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at patient records, not a test of any new treatment.
The short version
Doctors reviewed 283 adults with brain tumors and found that older patients tended to have more aggressive tumors and got less intensive treatment.
What was studied. Doctors at one hospital in Romania looked back at the records of 283 adults with diffuse glioma: A glioma whose cells spread out into the brain around it instead of staying in one lump. That is why the edge on a scan is not a clean line. See the glossary, a type of brain tumor, diagnosed between 2021 and 2024. They compared scans, tumor lab tests, treatment, and outcomes in three age groups: under 40, 40 to 60, and over 60.
What they found. Older patients more often had the type called IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary wildtype glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary. Their brain scans more often showed aggressive features, they were in poorer general health, and they were given less intensive treatment. Tumors also came back sooner in the older groups.
What this means, and what it doesn't
What it could mean: Age often goes along with other things that affect how a tumor behaves and what treatment a person can handle. The authors say the poorer results in older patients likely come from all of those things together, not from age by itself. The study also shows that this hospital was still rolling out tumor gene testing, so not every patient got it.
What it doesn't mean: This is not a new treatment and not a cure. Nothing new was tested here. The doctors only looked back at records that already existed, at one hospital, in one country. It cannot tell you what will happen to any one person. And it does not mean an older patient should get less treatment.
Source: PubMed, May 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.